Literature DB >> 27482544

Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.

Marcin P Iwanicki1, Hsing-Yu Chen1, Claudia Iavarone1, Ioannis K Zervantonakis1, Taru Muranen1, Marián Novak2, Tan A Ince3, Ronny Drapkin2,4, Joan S Brugge1.   

Abstract

High-grade serous ovarian carcinoma (HGS-OvCa) harbors p53 mutations and can originate from the epithelial cell compartment of the fallopian tube fimbriae. From this site, neoplastic cells detach, survive in the peritoneal cavity, and form cellular clusters that intercalate into the mesothelium to form ovarian and peritoneal masses. To examine the contribution of mutant p53 to phenotypic alterations associated with HGS-OvCA, we developed live-cell microscopy assays that recapitulate these early events in cultured fallopian tube nonciliated epithelial (FNE) cells. Expression of stabilizing mutant variants of p53, but not depletion of endogenous wild-type p53, in FNE cells promoted survival and cell-cell aggregation under conditions of cell detachment, leading to the formation of cell clusters with mesothelium-intercalation capacity. Mutant p53R175H-induced phenotypes were dependent on fibronectin production, α5β1 fibronectin receptor engagement, and TWIST1 expression. These results indicate that FNE cells expressing stabilizing p53 mutants acquire anchorage independence and subsequent mesothelial intercalation capacity through a mechanism involving mesenchymal transition and matrix production. These findings provide important new insights into activities of mutant p53 in the cells of origin of HGS-OvCa.

Entities:  

Year:  2016        PMID: 27482544      PMCID: PMC4963159          DOI: 10.1172/jci.insight.86829

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  82 in total

1.  Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.

Authors:  Thapi Dharma Rao; Kay J Park; Peter Smith-Jones; Alexia Iasonos; Irina Linkov; Robert A Soslow; David R Spriggs
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-10

Review 2.  Cancer of the ovary.

Authors:  Stephen A Cannistra
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

3.  P63 regulates tubular formation via epithelial-to-mesenchymal transition.

Authors:  Y Zhang; W Yan; X Chen
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

4.  Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.

Authors:  Russell Vang; Douglas A Levine; Robert A Soslow; Charles Zaloudek; Ie-Ming Shih; Robert J Kurman
Journal:  Int J Gynecol Pathol       Date:  2016-01       Impact factor: 2.762

5.  Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.

Authors:  Amir A Jazaeri; Jennifer L Bryant; Hong Park; Hui Li; Neetu Dahiya; Mark H Stoler; James Stuart Ferriss; Anindya Dutta
Journal:  Neoplasia       Date:  2011-10       Impact factor: 5.715

6.  Serous carcinogenesis in the fallopian tube: a descriptive classification.

Authors:  Elke Jarboe; Ann Folkins; Marisa R Nucci; David Kindelberger; Ronny Drapkin; Alexander Miron; Yonghee Lee; Christopher P Crum
Journal:  Int J Gynecol Pathol       Date:  2008-01       Impact factor: 2.762

Review 7.  Multicellular spheroids in ovarian cancer metastases: Biology and pathology.

Authors:  Kristy Shield; M Leigh Ackland; Nuzhat Ahmed; Gregory E Rice
Journal:  Gynecol Oncol       Date:  2009-01-10       Impact factor: 5.482

8.  Notch3 overexpression promotes anoikis resistance in epithelial ovarian cancer via upregulation of COL4A2.

Authors:  Caitlin W Brown; Alexander S Brodsky; Richard N Freiman
Journal:  Mol Cancer Res       Date:  2014-08-28       Impact factor: 5.852

Review 9.  Small molecule compounds targeting the p53 pathway: are we finally making progress?

Authors:  Xin Yu; Sumana Narayanan; Alexei Vazquez; Darren R Carpizo
Journal:  Apoptosis       Date:  2014-07       Impact factor: 4.677

10.  Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.

Authors:  P Dong; M Karaayvaz; N Jia; M Kaneuchi; J Hamada; H Watari; S Sudo; J Ju; N Sakuragi
Journal:  Oncogene       Date:  2012-07-30       Impact factor: 9.867

View more
  21 in total

1.  A Novel TP53 Mutation Associated with TWIST1 and SIP1 Expression in an Aggressive Adrenocortical Carcinoma.

Authors:  Daniel Bulzico; Davi Coe Torres; Gerson Moura Ferreira; Bruno Ricardo Barreto Pires; Paulo Antônio Silvestre de Faria; Rocio Hassan; Eliana Abdelhay; Mario Vaisman; Leonardo Vieira Neto
Journal:  Endocr Pathol       Date:  2017-12       Impact factor: 3.943

Review 2.  Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance.

Authors:  Jonathan Cooper; Filippo G Giancotti
Journal:  Cancer Cell       Date:  2019-03-18       Impact factor: 31.743

3.  Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis.

Authors:  Suchitra Natarajan; Kaitlyn M Foreman; Michaela I Soriano; Ninna S Rossen; Hussein Shehade; Daniel R Fregoso; Joshua T Eggold; Venkatesh Krishnan; Oliver Dorigo; Adam J Krieg; Sarah C Heilshorn; Subarna Sinha; Katherine C Fuh; Erinn B Rankin
Journal:  Cancer Res       Date:  2019-03-12       Impact factor: 12.701

4.  PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma.

Authors:  Dima Ghannam-Shahbari; Eyal Jacob; Reli Rachel Kakun; Tanya Wasserman; Lina Korsensky; Ofir Sternfeld; Juliana Kagan; Debora Rosa Bublik; Sarit Aviel-Ronen; Keren Levanon; Edmond Sabo; Sarit Larisch; Moshe Oren; Dov Hershkovitz; Ruth Perets
Journal:  Oncogene       Date:  2018-01-30       Impact factor: 9.867

Review 5.  Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.

Authors:  Ugo Testa; Eleonora Petrucci; Luca Pasquini; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2018-02-01

6.  Role of the tumour protein P53 gene in human cervical squamous carcinoma cells: Discussing haematopoietic cell-specific protein 1-associated protein X-1-induced survival, migration and proliferation.

Authors:  Bing Qian; Li-Jun Zhao; Fang Teng; Ling-Juan Gao; Rong Shen
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

7.  Progesterone Receptors Promote Quiescence and Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models.

Authors:  Laura J Mauro; Megan I Seibel; Caroline H Diep; Angela Spartz; Carlos Perez Kerkvliet; Hari Singhal; Elizabeth M Swisher; Lauren E Schwartz; Ronny Drapkin; Siddharth Saini; Fatmata Sesay; Larisa Litovchick; Carol A Lange
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

Review 8.  Integrins in the Spotlight of Cancer.

Authors:  Daniela Bianconi; Matthias Unseld; Gerald W Prager
Journal:  Int J Mol Sci       Date:  2016-12-06       Impact factor: 5.923

9.  Mutant p53 stimulates cell invasion through an interaction with Rad21 in human ovarian cancer cells.

Authors:  Ji-Hye Ahn; Tae Jin Kim; Jae Ho Lee; Jung-Hye Choi
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

Review 10.  Pathogenesis and heterogeneity of ovarian cancer.

Authors:  Paul T Kroeger; Ronny Drapkin
Journal:  Curr Opin Obstet Gynecol       Date:  2017-02       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.